CMS Energy to Announce 2026 Third Quarter Results on October 27
JACKSON, Mich., Oct. 6, 2026 /PRNewswire/ -- CMS Energy announced today it will provide 2026 third quarter results along with a business and financial outlook at 10:00 a.m.
CMS - CMS Energy Corporation
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$78.45
DETAILS
HIGH:
$84.00
LOW:
$73.00
MEDIAN:
$79.00
CONSENSUS:
$78.45
UPSIDE:
20.06%
Stock News
Peter Thiel Was an Early Outside Investor in Facebook and Co-Founded Both PayPal and Palantir Before Building a Hedge Fund Now Concentrated in Power and Energy Stocks. Here's What That Track Record Says About Following His Contrarian Bets.
Peter Thiel has scored some big wins as a tech investor and company founder, but that doesn't mean everything he touches will turn to gold.
CMS Energy (NYSE:CMS) Reaches New 1-Year Low – Time to Sell?
CMS Energy Corporation (NYSE: CMS - Get Free Report)'s stock price reached a new 52-week low during trading on Tuesday. The stock traded as low as $62.29 and last traded at $62.9570, with a volume of 164696 shares. The stock had previously closed at $62.60. Analyst Upgrades and Downgrades Several research firms recently issued reports on
Labcorp: The CMS Selloff Represents An Excellent Opportunity - Strong Buy
Labcorp shares dropped sharply after CMS released preliminary 2027 lab-payment rates, aligning Medicare rates closer to private insurers and targeting $1B annual savings. I see the selloff as overdone, with market fears exaggerated by a misunderstanding of the CMS report's impact on LH's bottom line. The proposed cuts only affect Medicare's Clinical Laboratory Fee Schedule, with annual reimbursement reductions capped at 15% and final rates pending.
CMS Energy (NYSE:CMS) Sets New 52-Week Low – Here’s Why
CMS Energy Corporation (NYSE: CMS - Get Free Report) hit a new 52-week low during trading on Wednesday. The company traded as low as $64.19 and last traded at $64.2480, with a volume of 4446236 shares changing hands. The stock had previously closed at $64.70. Wall Street Analysts Forecast Growth Several equities analysts recently weighed
CMS Energy (NYSE:CMS) Hits New 52-Week Low – What’s Next?
Shares of CMS Energy Corporation (NYSE: CMS - Get Free Report) reached a new 52-week low during trading on Thursday. The stock traded as low as $65.67 and last traded at $65.9950, with a volume of 2050103 shares. The stock had previously closed at $65.92. Analyst Ratings Changes Several research firms have commented on CMS.
CMS Energy Corporation $CMS Shares Sold by Corient Private Wealth LP
Corient Private Wealth LP reduced its stake in CMS Energy Corporation (NYSE: CMS) by 5.5% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 147,623 shares of the utilities provider's stock after selling 8,599 shares during the quarter. Corient Private Wealth LP's holdings
CMS Energy: Snatch Up This Future Dividend Aristocrat Now
CMS Energy remains positioned to become a Dividend Aristocrat early next decade. The regulated utility topped the analyst consensus for both operating revenue and adjusted EPS in the second quarter. CMS Energy possesses a BBB S&P credit rating with a stable outlook.
Nykredit A S Buys New Position in CMS Energy Corporation $CMS
Nykredit A S bought a new stake in CMS Energy Corporation (NYSE: CMS) in the undefined quarter, according to its most recent disclosure with the SEC. The fund bought 17,941 shares of the utilities provider's stock, valued at approximately $1,372,000. A number of other institutional investors and hedge funds also recently bought and
CMS(867.HK/8A8.SG): Innovative Drug Lumirix® Approved in China for Additional Indication of Atopic Dermatitis (AD)
SHENZHEN, CHINA, Sept. 03, 2026 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company specialized in skin health which is applying for a separate listing on the Main Board of The Stock Exchange of Hong Kong Limited) received the approval from the National Medical Products Administration of China (NMPA) for the New Drug Application (NDA) of ruxolitinib phosphate cream (Lumirix®) for the treatment of mild to moderate atopic dermatitis (“AD”) on 2 September 2026. The drug registration certificate was obtained on 3 September 2026. The product is indicated for the topical short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis in non-immunocompromised adult and pediatric patients 2 years of age and older whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable.
Peter Thiel's Fund Reported Zero Stocks for 2 Straight Quarters. Its $419 Million Comeback Put 72% Into Energy and Power.
The fund reported nothing for six months. Its comeback filing lists one tech stock and seven energy bets.
Why Is CMS Energy (CMS) Down 6.9% Since Last Earnings Report?
CMS Energy (CMS) reported earnings 30 days ago. What's next for the stock?
Longstanding Bridgeline Customer Expands from CMS to HawkSearch AI Search and Shopping Assistant
WOBURN, MA / ACCESS Newswire / August 25, 2026 / Bridgeline Digital, Inc. (NASDAQ:BLIN), a leader in AI-powered product discovery and eCommerce solutions, announced today that a longstanding customer of its Content Management Platform has expanded its relationship with Bridgeline through the adoption of HawkSearch, including Concept and Unified Search, Smart Response, and Shopping Assistant. The multi-year engagement highlights growing demand for AI-powered search and assistant technologies among Bridgeline's existing customer base.
Peter Thiel's $418 Million Bet On These 8 Companies Reveals AI's Biggest Bottleneck
Thiel Macro LLC resurfaced in mid-August with a $418.7 million book spread across exactly eight positions as of June 30, 2026, according to 13f.info's rendering of the filing.
Danske Bank A S Invests $1.53 Million in CMS Energy Corporation $CMS
Danske Bank A S acquired a new stake in CMS Energy Corporation (NYSE: CMS) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 20,000 shares of the utilities provider's stock, valued at approximately $1,530,000. Other institutional investors have also
CMS Energy: Preferred Stock Still Preferred
CMS Energy is rated Hold due to uncertainties in affordability, data center positioning, and recent CFO transition despite solid regulatory support. CMS plans to sell most non-regulated renewables, targeting $500M net proceeds to fund regulated rate base expansion and focus on core utility operations. CMS faces high storm damage costs, aggressive $25.8B capex plan, and regulatory risks, with electricity affordability likely a key election-year issue.
CMS Energy Declares Quarterly Dividend on Cumulative Redeemable Perpetual Preferred Stock
JACKSON, Mich., Aug. 6, 2026 /PRNewswire/ -- The Board of Directors of CMS Energy has declared a dividend on the 4.200% Cumulative Redeemable Perpetual Preferred Stock, Series C of the Corporation.
Consumers Energy, the Principal Subsidiary of CMS Energy, Declares Quarterly Dividend on Preferred Stock
Consumers Energy, the Principal Subsidiary of CMS Energy, Declares Quarterly Dividend on Preferred Stock PR Newswire
Consumers Energy, the Principal Subsidiary of CMS Energy, Declares Quarterly Dividend on Preferred Stock
JACKSON, Mich., Aug. 6, 2026 /PRNewswire/ -- The Board of Directors of Consumers Energy, the principal subsidiary of CMS Energy, has declared a quarterly dividend on the utility's preferred stock.
CMS and MaxLinear Expand OpenZFS Storage for AI, Cloud, and Hyperscale Infrastructure
MaxLinear, Inc. (NASDAQ: MXL), a leading provider of high-performance connectivity and data movement solutions, today announced that Core Micro Systems (CMS), a
Price Targets
CMS Energy (CMS) PT Lowered to $73 at BMO Capital
$73.00
(was $64.55)
RBC Capital
CMS Energy (CMS) PT Lowered to $73 at BMO Capital
$73.00
(was $64.55)
Capital One Financial
CMS Energy price target lowered to $73 from $77 at BMO Capital
$73.00
(was $64.03)
BMO Capital
Scotiabank Reiterates Sector Outperform Rating on CMS Energy (CMS)
$78.00
(was $63.08)
Andrew Weisel
·
Scotiabank
CMS Energy price target lowered to $77 from $82 at BMO Capital
$77.00
(was $68.46)
James Thalacker
·
BMO Capital
CMS Energy price target lowered to $79 from $80 at Morgan Stanley
$79.00
(was $69.81)
Morgan Stanley
CMS Energy price target lowered to $81 from $85 at Truist
$81.00
(was $71.74)
Richard Sunderland
·
Truist Financial
CMS Energy price target raised to $84 from $83 at UBS
$84.00
(was $74.37)
UBS
CMS Energy price target raised to $86 from $81 at BMO Capital
$86.00
(was $73.65)
James Thalacker
·
BMO Capital
CMS Energy (CMS) PT Raised to $78 at JefferiesMember Login
$78.00
(was $74.03)
Jefferies
CMS Energy price target raised to $81 from $79 at Barclays
$81.00
(was $75.75)
Barclays
KeyBanc Reiterates Overweight Rating on CMS Energy (CMS) Following CFO Transition
$83.00
(was $71.31)
Sophie Karp
·
KeyBanc
CMS Energy price target lowered to $81 from $82 at BMO Capital
$81.00
(was $70.22)
James Thalacker
·
BMO Capital
CMS Energy downgraded to Hold from Buy at Jefferies
$74.00
(was $70.22)
Julien Dumoulin-Smith
·
Jefferies
CMS Energy price target lowered to $77 from $81 at Morgan Stanley
$77.00
(was $73.46)
Morgan Stanley
CMS Energy price target lowered to $83 from $86 at Truist
$83.00
(was $71.64)
Truist Financial
CMS Energy price target lowered to $82 from $85 at BMO Capital
$82.00
(was $72.97)
BMO Capital
CMS Energy price target raised to $80 from $74 at Wells Fargo
$80.00
(was $77.04)
Wells Fargo
CMS Energy price target lowered to $85 from $86 at BMO Capital
$85.00
(was $78.11)
BMO Capital
CMS Energy price target raised to $79 from $74 at Barclays
$79.00
(was $75.86)
Barclays